FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LADUVIGLUSIB
异名/同义词3-PYRIDINECARBONITRILE, 6-((2-((4-(2,4-DICHLOROPHENYL)-5-(5-METHYL-1H-IMIDAZOL-2-YL)-2-PYRIMIDINYL)AMINO)ETHYL)AMINO)-
6-((2-((4-(2,4-DICHLOROPHENYL)-5-(4-METHYL-1H-IMIDAZOL-2-YL)PYRIMIDIN-2-YL)AMINO)ETHYL)AMINO)NICOTINONITRILE
CHIR-911
CHIR-99021
CHR00921
CHR-00921
CT99021
CT-99021
FX03
LADUVIGLUSIB
LADUVIGLUSIB [INN]
LADUVIGLUSIB [USAN]
CAS登记号252917-06-9
物质唯一标识(Unique Ingredient Identifier)234CMT4GK4
分子式C22H18Cl2N8
国际化合物标识(International Chemical Identifier,InChI)AQGNHMOJWBZFQQ-UHFFFAOYSA-N
SMILESC(c1ccc(nc1)NCCNc2nc(c(cn2)-c3nc(c[nH]3)C)-c4c(cc(cc4)Cl)Cl)#N
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System